The Disease Burden of the Most Common Autoimmune Diseases

Area of Science:

• Immunology
• Gastroenterology
• Rheumatology
• Dermatology

Background:

• Immune-mediated inflammatory diseases (IMIDs) like inflammatory bowel disease (IBD), rheumatoid arthritis (RA), and psoriasis impose substantial health and financial burdens.
• These conditions collectively affect approximately 10 million individuals in the United States, comparable in impact to stroke and lower back pain.
• The etiology of these chronic diseases remains largely unknown, and current treatments do not offer a cure.

Purpose of the Study:

• To underscore the significant public health impact of IBD, RA, and psoriasis.
• To highlight the comparable disease burden of these IMIDs to other major chronic conditions.
• To emphasize the need for further research into the etiology and treatment of these incurable diseases.

Main Methods:

• Comparative analysis of disease burden metrics.
• Epidemiological data review for IBD, RA, and psoriasis prevalence in the US.
• Benchmarking against established chronic conditions such as stroke and lower back pain.

Main Results:

• The financial and health toll of IBD, RA, and psoriasis is comparable to that of stroke and lower back pain.
• Approximately 10 million patients in the United States are affected by these conditions.
• These diseases are characterized by immune-mediated inflammation of unknown origin.

Conclusions:

• Inflammatory bowel disease, rheumatoid arthritis, and psoriasis represent a major, often underestimated, public health challenge.
• The lack of a cure for these chronic immune-mediated conditions necessitates urgent advancements in research and therapeutic strategies.
• Further investigation into the underlying causes is crucial for developing effective treatments and potential cures.